The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Ethnopharmacological Relevance Bacopa monnieri (L) Wettst (common name, bacopa) is a medicinal plant used in Ayurveda, the traditional system of medicine of India, as a nootropic. It is considered to be a “medhya rasayana”, an herb that sharpens the mind and the intellect. Bacopa is an important ingredient in many Ayurvedic herbal formulations designed to treat conditions such as memory loss, anxiety, poor cognition and loss of concentration. It has also been used in Ayurveda to treat inflammatory conditions such as arthritis. In modern biomedical studies, bacopa has been shown in animal models to inhibit the release of the pro-inflammatory cytokines TNF-α and IL-6. However, less is known regarding the anti-inflammatory activity of Bacopa in the brain. Aim Of The Study The current study examines the ability of Bacopa to inhibit the release of pro-inflammatory cytokines from microglial cells, the immune cells of the brain that participate in inflammation in the CNS. The effect of Bacopa on signaling enzymes associated with CNS inflammatory pathways was also studied. Materials And Methods Various extracts of Bacopa were prepared and examined in the N9 microglial cell line in order to determine if they inhibited the release of the proinflammatory cytokines TNF-α and IL-6. Extracts were also tested in cell free assays as inhibitors of caspase-1 and matrix metalloproteinase-3 (enzymes associated with inflammation) and caspase-3, which has been shown to cleave protein Tau, an early event in the development of Alzheimer's disease. Results The tea, infusion, and alkaloid extracts of bacopa, as well as Bacoside A significantly inhibited the release of TNF-α and IL-6 from activated N9 microglial cells in vitro. In addition, the tea, infusion, and alkaloid extracts of Bacopa effectively inhibited caspase 1 and 3, and matrix metalloproteinase-3 in the cell free assay. Conclusions Bacopa inhibits the release of inflammatory cytokines from microglial cells and inhibits enzymes associated with inflammation in the brain. Thus, Bacopa can limit inflammation in the CNS, and offers a promising source of novel therapeutics for the treatment of many CNS disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1703 · Cited by 1,834 · cited 2×
“…and cancers (Lee et al., 2010; Roy et al., 2009), 2) caspase 1: involved in the activation of pro-inflammatory cytokines and chronic inflammation (Franchi et al., 2009), and 3) caspase 3: an executioner caspase involved in apoptosis and the development of Alzheimer's diseases and other…”
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · cited 1×
“…cytokines such as Tumor Necrosis Factor alpha (TNF-α) and Interleukin 6 (IL-6), and the M2 phenotype that produces the anti-inflammatory cytokine IL-10 and downregulates the M1 response (Nakagawa and Chiba, 2015; Gonzalez et al., 2014; Ganguly and Brenhouse, 2014; Heneka et al., 2014).”
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Tumor necrosis factor alpha: A link between neuroinflammation and excitotoxicity
Olmos, G., & Lladó, J. (2014) · Mediators of Inflammation · doi:10.1155/2014/861231 · Cited by 730 · cited 2×
“…conditions within the CNS, microglia and to some extent astrocytes, release TNF-α and this contributes to the neuroinflammation associated with various neurological diseases including Alzheimer's disease, Parkinson's disease, traumatic brain injury, and ischemia (Olmos and Llado, 2014).”
Bacopa monniera, a reputed nootropic plant: An overview
Russo, A., & Borrelli, F. (2005) · Phytomedicine · doi:10.1016/j.phymed.2003.12.008 · Cited by 447 · cited 2×
“(Lurie and Coffin, 2015; Russo and Borrelli, 2005; Shinomol and Muralidhara, 2011; Williamson, 2002).”
González, H., Elgueta, D., Montoya, A., & Pacheco, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.012 · Cited by 352 · cited 1×
“…cytokines such as Tumor Necrosis Factor alpha (TNF-α) and Interleukin 6 (IL-6), and the M2 phenotype that produces the anti-inflammatory cytokine IL-10 and downregulates the M1 response (Nakagawa and Chiba, 2015; Gonzalez et al., 2014; Ganguly and Brenhouse, 2014; Heneka et al., 2014).”
Jha, S., Srivastava, S. Y., Brickey, W. J., Iocca, H., Toews, A., Morrison, J. P., Chen, V. S., Gris, D., Matsushima, G. K., & Ting, J. P.-Y. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4088-10.2010 · Cited by 310 · cited 3×
“Specific caspase-1 inhibitors have been proposed as potential therapies for many neurodegenerative disorders including Parkinson's (Jha et al., 2010) and Alzheimer's diseases (Gamblin et al., 2003), as well as certain cancers (Granot et al., 2006; Lewis et al., 2006; Schlosser et al., 2001).”
Neuropharmacological Review of the Nootropic Herb Bacopa monnieri
Aguiar, S., & Borowski, T. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1431 · Cited by 295 · cited 1×
“Bacopa is used in Ayurveda as a nootropic to improve intellect and memory and is an important component of many Ayurvedic herbal formulations that target the CNS and manage conditions such as memory, lack of concentration, and anxiety (Aguiar and Borowski, 2013).”
IL-6 regulation of synaptic function in the CNS
Gruol, D. L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.023 · Cited by 254
Diversity and plasticity of microglial cells in psychiatric and neurological disorders
Nakagawa, Y., & Chiba, K. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.010 · Cited by 208 · cited 4×
“Microglia exist in two distinct functional states; the M1 phenotype that produces proinflammatory cytokines such as Tumor Necrosis Factor alpha (TNF-α) and Interleukin 6 (IL-6), and the M2 phenotype that produces the anti-inflammatory cytokine IL-10 and downregulates the M1 response (Nakagawa and Chiba, 2015; Gonzalez…”
Influential
Cited by
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
Peterson, C. T. (2020) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x20957225 · Cited by 160
“Clinical trials (Table 2) in patients with age-associated memory impairment and healthy elderly subjects suggest that treatment improves focus, memory and learning outcomes.(104,109,110,142-145) One clinical trial examined bacopa, although in a polyherbal blend with 2 other herbs, in senile dementia of Alzheimer type.”
BackgroundBrahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease
Dubey, T., & Chinnathambi, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108153 · Cited by 151
Valotto Neto, L. J., Reverete de Araujo, M., Moretti Junior, R. C., Mendes Machado, N., Joshi, R. K., dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., Tanaka, M., et al. (2024) · Antioxidants · doi:10.3390/antiox13040393 · Cited by 146
“Therefore, Bacopa has the potential to attenuate inflammatory processes in the CNS and emerges as a promising source for the development of new therapeutic approaches targeting various neurological disorders [138].”
Sushma, Sahu, M. R., Murugan, N. A., & Mondal, A. C. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300245 · Cited by 17
Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature
Tang, S. W., Tang, W. H., & Leonard, B. E. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1346279 · Cited by 11
Treatment of Alzheimer’s disease by natural products
CHOUGLE, S., KUMAR, D., KHAN, A., ZEHRA, S., & ALİ, A. (2021) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.38.4.42 · Cited by 8
“(59) in cell free assay system, complete inhibition of caspase 1 and 3 was seen while, significant inhibition of TNF-α and IL-6 release from LPS-activated microglia was observed (59).”
Metadata
- Authors
- Nemetchek, M. D., Stierle, A. A., Stierle, D. B., & Lurie, D. I.
- Venue
- Journal of Ethnopharmacology
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 197
- Pages
- 92-100
- ISSN
- 0378-8741 (ISSN-L)
- OpenAlex
- W2486540121
- Cited by
- 158
- References
- 13
- FWCI
- 11.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.